Consistent with these conclusions, we found that the expression of FAM66C in high-risk patients was significantly lower than that in low-risk patients, suggesting that FAM66C is more likely to play the role of a tumor suppressor gene in tumor cells and prevent tumor progression. The gene discussed is FAM66C; the disease is neoplasm.